 | Up a level |
Granana-Castillo, Sandra, Montanha, Maiara Camotti, Bearon, Rachel 
ORCID: 0000-0001-8461-0823, Khoo, Saye and Siccardi, Marco ORCID: 0000-0002-3539-7867
(2022)
Evaluation of drug-drug interaction between rilpivirine and rifapentine using PBPK modelling.
FRONTIERS IN PHARMACOLOGY, 13.
1076266-.
Castillo, Sandra Grañana, Montanha, Maiara Camotti, Bearon, Rachel ORCID: 0000-0001-8461-0823, Khoo, Saye and Siccardi, Marco
(2022)
Evaluation of drug-drug interaction between rilpivirine and rifapentine using physiologically based pharmacokinetic modelling.
Frontiers in Pharmacology.
Castillo, Sandra Grañana, Montanha, Maiara Camotti, Bearon, Rachel ORCID: 0000-0001-8461-0823, Khoo, Saye ORCID: 0000-0002-2769-0967 and Siccardi, Marco
(2022)
Evaluation of drug-drug interaction between rilpivirine and rifapentine using physiologically based pharmacokinetic modelling.
Frontiers in Pharmacology.
Montanha, Maiara Camotti, Cottura, Nicolas ORCID: 0000-0003-3083-2249, Booth, Michael, Hodge, Daryl ORCID: 0000-0003-2288-7020, Bunglawala, Fazila, Kinvig, Hannah, Granana-Castillo, Sandra, Lloyd, Andrew, Khoo, Saye ORCID: 0000-0002-2769-0967 and Siccardi, Marco ORCID: 0000-0002-3539-7867
(2022)
PBPK Modelling of Dexamethasone in Patients With COVID-19 and Liver Disease.
FRONTIERS IN PHARMACOLOGY, 13.
814134-.
Montanha, Maiara Camotti, Fabrega, Francesc, Howarth, Alice ORCID: 0000-0003-2288-1745, Cottura, Nicolas ORCID: 0000-0003-3083-2249, Kinvig, Hannah, Bunglawala, Fazila, Lloyd, Andrew, Denti, Paolo, Waitt, Catriona ORCID: 0000-0003-0134-5855 and Siccardi, Marco ORCID: 0000-0002-3539-7867
(2021)
Predicting Drug-Drug Interactions between Rifampicin and Ritonavir-Boosted Atazanavir Using PBPK Modelling.
CLINICAL PHARMACOKINETICS, 61 (3).
pp. 375-386.
Montanha, Maiara Camotti, Howarth, Alice ORCID: 0000-0003-2288-1745, Mohamed, Doaa Ahmed, Loier, Estelle, Main, Lauren, Rosslein, Matthias, Delmaar, Christiaan, Prina-Mello, Adriele and Siccardi, Marco ORCID: 0000-0002-3539-7867
(2022)
A physiologically based pharmacokinetic model to predict pegylated liposomal doxorubicin disposition in rats and human.
DRUG DELIVERY AND TRANSLATIONAL RESEARCH, 12 (9).
pp. 2178-2186.